Trident 542-11-42BRecalls & reported problems
Howmedica Osteonics Corp. · Cluster Acetabular Shell · Class 2 · Implant
- Adverse event reports
- 4
- Deaths reported
- 0
- Injuries reported
- 4
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 04546540240446), received between Nov 3, 2020 and Jul 6, 2021 — classified as 4 injuries.
The most frequently reported specific device problem is “Osseointegration Problem” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.
Most reported problems
Device problems
- Osseointegration Problem2
- Fracture1
- Loosening of Implant Not Related to Bone-Ingrowth1
- Loss of Osseointegration1
- Malposition of Device1
Patient problems
- Bone Fracture(s)2
- Inadequate Osseointegration2
- Insufficient Information1
Recent adverse event reports
The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.
InjuryJul 6, 2021Osseointegration Problem; Osseointegration Problem
THE FOLLOWING WAS REPORTED: LOOSENING. DATE OF SURGERY AND EVENT DATE ARE UNKNOWN. 4 YEARS AFTER THE PROCEDURE. DEVICE IS TRIDENT PSL, BUT SIZE IS UNKNOWN.
Patient problems: Inadequate Osseointegration
MAUDE report 12125638 ↗InjuryJul 5, 2021Osseointegration Problem; Osseointegration Problem
LOOSENING. NO INFECTION. NO REVISION IS PLANNED SO FAR. PRIMARY SURGERY DATE IS UNKNOWN.
Patient problems: Insufficient Information
MAUDE report 12116202 ↗InjuryNov 3, 2020Fracture; Fracture
INTRAOPERATIVE ACETABULAR FRACTURE. EVENT WAS NOTED IN EVENT DESCRIPTION OF (B)(4). UPDATE 16 OCTOBER 2020: INTERVENTION FOR THE FRACTURE WAS UNCLEAR, BUT SCREWS WERE PLACED IN THE CUP.
Patient problems: Bone Fracture(s)
MAUDE report 10780159 ↗InjuryNov 3, 2020Loss of Osseointegration; Malposition of Device; Loosening of Implant Not Related to Bone-Ingrowth; Loss of Osseointegration; Malposition of Device; Loosening of Implant Not Related to Bone-Ingrowth
42MM TRIDENT CUP WAS REVISED FOR LOOSENING. INITIAL SURGERY WAS DONE ON (B)(6) 2016 - SURGEON REPORTED AN INTRA OPERATIVE ACETABULAR FRACTURE, WHICH DID NOT HEAL AND LED TO CUP LOOSENING.
Patient problems: Bone Fracture(s); Inadequate Osseointegration
MAUDE report 10779484 ↗
Other Prosthesis, hip, semi-constrained, metal/ceramic/polymer, cemented or non-porous cemented, osteophilic finish devices
- Arcos Modular Revision Hip System 11-301310Biomet Orthopedics, LLC · Prosthesis, hip, semi-constrained, metal/ceramic/polymer, cemented or non-porous cemented, osteophilic finish1 recall9 reports
- Arcos Modular Revision Hip System 11-301342Biomet Orthopedics, LLC · Prosthesis, hip, semi-constrained, metal/ceramic/polymer, cemented or non-porous cemented, osteophilic finish1 recall4 reports
- Tritanium 502-03-52DHowmedica Osteonics Corp. · Prosthesis, hip, semi-constrained, metal/ceramic/polymer, cemented or non-porous cemented, osteophilic finish39 reports
- V40 Head 6260-5-332Howmedica Osteonics Corp. · Prosthesis, hip, semi-constrained, metal/ceramic/polymer, cemented or non-porous cemented, osteophilic finish12 reports
- V40 Head 6260-9-032Howmedica Osteonics Corp. · Prosthesis, hip, semi-constrained, metal/ceramic/polymer, cemented or non-porous cemented, osteophilic finish11 reports
- EXETER 0580-1-443Howmedica Osteonics Corp. · Prosthesis, hip, semi-constrained, metal/ceramic/polymer, cemented or non-porous cemented, osteophilic finish11 reports
- Trident 509-02-56EHowmedica Osteonics Corp. · Prosthesis, hip, semi-constrained, metal/ceramic/polymer, cemented or non-porous cemented, osteophilic finish10 reports
- Taperloc Complete Primary Femoral 51-104180Biomet Orthopedics, LLC · Prosthesis, hip, semi-constrained, metal/ceramic/polymer, cemented or non-porous cemented, osteophilic finish9 reports
Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.